IL2 and cancer: Increased Bifidobacterium, Lactobacillus, secretion of IL-2 by PBMC, and production of IFN-γ. Decreased Clostridium perfringens, significantly reduced colorectal proliferation and induced necrosis in colonic cells, improved epithelial barrier function in patients in cancer patients.